• Biomarkers in prostate-specific membrane antigen theranostics 

      Vlachostergios P.J., Zachos I., Tzortzis V. (2021)
      Theranostics of prostate cancer (PC) represents a growing area of development of imaging agents and targeted radionuclide therapeutics against a major target, prostate specific membrane antigen (PSMA). In view of the ...
    • Organs dosimetry in targeted radionuclide therapy 

      Alnaaimi M., Sulieman A., Alkhorayef M., Salah H., Alduaij M., Algaily M., Alomair O., Alashban Y., Almohammad H.I., Bradley D., Kappas C. (2021)
      The objective of this study is to assess the patients' effective and organ dose during theranostic applications in Kuwait. In total, eighteen adults' patients were conducted nuclear medicine procedures with 177Lu Dotatate ...
    • Radiolabeled mAbs as Molecular Imaging and/or Therapy Agents Targeting PSMA 

      Psimadas D., Valotassiou V., Alexiou S., Tsougos I., Georgoulias P. (2018)
      Molecular imaging and therapy is a rapidly evolving field in research and clinical medicine. The use of the exciting and attractive properties of radioisotopes for imaging and therapy has made Nuclear Medicine very significant ...